Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
11.15
+0.33 (3.05%)
Jun 2, 2025, 11:02 AM - Market open

Niagen Bioscience Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Niagen Bioscience stock ranges from a low of $11 to a high of $13. The average analyst price target of $12 forecasts a 7.62% increase in the stock price over the next year.

Price Target: $12.00 (+7.62%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $12 $13 $13
Change -1.35% +7.62% +16.59% +16.59%

Analyst Ratings

The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '25May '25
Strong Buy 12
Buy 00
Hold 00
Sell 00
Strong Sell 00
Total 12

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Canaccord Genuity
Canaccord Genuity
Strong Buy
Initiates
$13
Strong Buy Initiates $13 +16.59% May 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 -1.35% Apr 8, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 -1.35% Mar 31, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
124.95M
from 99.60M
Increased by 25.46%
Revenue Next Year
152.09M
from 124.95M
Increased by 21.72%
EPS This Year
0.13
from 0.11
Increased by 14.36%
EPS Next Year
0.22
from 0.13
Increased by 72.97%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
59.26M67.45M72.05M83.57M99.60M124.95M152.09M180.94M
Revenue Growth
28.01%13.83%6.82%15.99%19.18%25.46%21.72%18.97%
EPS
-0.33-0.40-0.24-0.070.110.130.220.37
EPS Growth
-----14.36%72.97%71.10%
Forward PE
-----88.6451.2429.95
No. Analysts
-----654
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 129.9M 159.7M 189.7M
Avg 125.0M 152.1M 180.9M
Low 119.3M 142.9M 170.6M

Revenue Growth

Revenue Growth 202520262027
High
30.4%
27.8%
24.8%
Avg
25.5%
21.7%
19.0%
Low
19.8%
14.4%
12.2%

EPS Forecast

EPS 202520262027
High 0.20 0.28 0.41
Avg 0.13 0.22 0.37
Low 0.08 0.17 0.33

EPS Growth

EPS Growth 202520262027
High
81.4%
125.4%
88.2%
Avg
14.4%
73.0%
71.1%
Low
-28.7%
32.4%
53.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.